Analyst Ratings for Oncternal Therapeutics (ONCT)

ONCT Rating Summary

  |   Expand Research on ONCT
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 4.3 / 10   Percentile Rank: 43%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
9/12/2024 Northland Carl Byrnes Downgrade Market Perform
(Outperform)		 2.00
(N/A)		 4.16
(0.53)		 -87.26% Details
9/12/2024 Brookline Capital Markets Kemp Dolliver Downgrade Hold
(Buy)		 N/A
(N/A)		 4.16
(0.53)		 -87.26% Details